Announcement on Voluntary Disclosure on the Acceptance of Conditional Listing Application for GR1803 Injection
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Filed with SSE · · 2 pages · Chinese
The application is for a drug intended for adult patients with relapsed or refractory multiple myeloma who have undergone at least three lines of treatment.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Announcement on Voluntary Disclosure on the Acceptance of Conditional Listing Application for GR1803 Injection
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Chongqing Genrix Biopharmaceutical Co., Ltd. on 6ix
Follow Chongqing Genrix Biopharmaceutical into a list and get an email when it puts out news.
Follow Chongqing Genrix Biopharmaceutical